Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Accounts Payables (2023 - 2025)

Historic Accounts Payables for SANUWAVE Health (SNWV) over the last 10 years, with Q3 2025 value amounting to $4.0 million.

  • SANUWAVE Health's Accounts Payables fell 350.5% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 350.5%. This contributed to the annual value of $3.7 million for FY2024, which is 3465.38% down from last year.
  • As of Q3 2025, SANUWAVE Health's Accounts Payables stood at $4.0 million, which was down 350.5% from $4.0 million recorded in Q2 2025.
  • SANUWAVE Health's Accounts Payables' 5-year high stood at $5.7 million during Q4 2023, with a 5-year trough of $3.7 million in Q4 2024.
  • Over the past 3 years, SANUWAVE Health's median Accounts Payables value was $4.2 million (recorded in 2025), while the average stood at $4.5 million.
  • In the last 5 years, SANUWAVE Health's Accounts Payables crashed by 3465.38% in 2024 and then soared by 285.27% in 2025.
  • Over the past 3 years, SANUWAVE Health's Accounts Payables (Quarter) stood at $5.7 million in 2023, then plummeted by 34.65% to $3.7 million in 2024, then increased by 7.08% to $4.0 million in 2025.
  • Its Accounts Payables was $4.0 million in Q3 2025, compared to $4.0 million in Q2 2025 and $4.2 million in Q1 2025.